Summary
This feasibility study has shown that the novel technology of AI-led
telephone calls using automated voice assistants can be delivered to
patients with USHNC with a high level of data capture (95%) and
accuracy (89%) when compared to clinicians. Patients on this pathway
were highly likely to recommend this novel technology to a friend or
family member (NPS average 8 out of 10).